Antibody Engineering & Therapeutics Europe 2026

Biointron is pleased to announce our participation in Antibody Engineering & Therapeutics Europe 2026, taking place May 27 – 29, 2026, at the Congress Center Basel in Basel, Switzerland. As one of Europe’s leading scientific conferences focused on antibody and protein therapeutic innovation, this event brings together researchers, developers, and industry experts from around the world to explore the latest advances in antibody engineering, therapeutic strategies, and discovery technologies.  

Antibody Engineering & Therapeutics Europe 2026 will deliver a rich agenda of sessions and discussions covering cutting-edge topics such as novel approaches to antibody discovery, multispecific formats, Fc engineering, conditionally active biologics, ADCs and bioconjugates, as well as the integration of computational methods into biologics research and development. The conference fosters deep scientific exchange and provides a collaborative platform to accelerate progress from early discovery to therapeutic impact.  

Biointron looks forward to engaging with fellow innovators, sharing insights, and contributing to discussions that help shape the future of antibody-based therapeutics. Visit our booth #13, we’re excited to connect with the vibrant scientific community in Basel this May and explore new opportunities to drive therapeutic innovation forward at Antibody Engineering & Therapeutics Europe 2026. 

For more details about the event, please visit the Antibody Engineering & Therapeutics Europe 2026 website [https://informaconnect.com/antibody-engineering-europe/] 

Time: May 27 – 29, 2026 

Location: Congress Center Basel | Basel, Switzerland 

Booth: #13